Emerging evidence suggests that a cocktail approach, that is, incorporating not only senolytics and senomorphics but also other therapeutic modalities, such as antioxidants, immune modulators, or metabolic enhancers may have a compounded effect in promoting healthy aging
Diabetes 73 , 10581071 (2024)
I know some people who cant hear that song [Breathe Me] without crying
The science of Microdosing GLP-1 Broad clinical potential: Commonly used to treat type 2 diabetes and weight management, GLP-1 medications act on GLP-1 receptors located in the brain, gut, and immune system, impacting multiple biomarkers. Recent studies have begun exploring low doses of GLP-1 medications for broader health goals beyond glucose control and weight loss. Emerging research in healthspan and longevity: In a series of studies, low doses of GLP-1 receptor agonists were shown to modulate inflammatory pathways, support mitochondrial function, and lower the risk of cognitive decline in study participantsgiving Microdosing GLP-1 promising potential for extending healthspan
